| CREB1 | A549 (lung carcinoma) | 1 h with 0.02% Ethanol (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BRA | MA0018.4 | 
  
    
    | CREB1 | A549 (lung carcinoma) | 1 h with 100 nM Dexamethasone (Myers) | Permissive | Homo sapiens | ENCSR000BRB | MA0018.4 | 
  
    
    | CREB1 | A549 (lung carcinoma) | 1 h with 0.02% Ethanol (Myers) | Permissive
      
      Robust | Homo sapiens | ENCSR000BRC | MA0018.4 | 
  
    
    | CREB1 | 3T3-L1 (embryonic fibroblasts) | DMSO | Permissive
      
      Robust | Mus musculus | GSE33821
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | 3T3-L1 (embryonic fibroblasts) | lactacystin | Permissive
      
      Robust | Mus musculus | GSE33821
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | liver | Fasted 24h | Permissive
      
      Robust | Mus musculus | GSE45674
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | liver | Fasted 24h, Re-fed 2h | Permissive
      
      Robust | Mus musculus | GSE45674
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | hepatocytes | fed 24 h | Permissive
      
      Robust | Mus musculus | GSE72084
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | hepatocytes | fasted 24 h | Permissive
      
      Robust | Mus musculus | GSE72084
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | hepatocytes | glucagon (10nM) for 1hr | Permissive
      
      Robust | Mus musculus | GSE72084
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | hepatocytes | glucagon (10nM) + corticosterone (1.7uM) for 1 hr | Permissive
      
      Robust | Mus musculus | GSE72084
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | brown preadipocytes | GR KO | Permissive
      
      Robust | Mus musculus | GSE76619
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | bone marrow-derived macrophages | lipid A 0 min | Permissive
      
      Robust | Mus musculus | GSE99895
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | bone marrow-derived macrophages | lipid A 15 min | Permissive
      
      Robust | Mus musculus | GSE99895
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | bone marrow-derived macrophages | lipid A 30 min | Permissive
      
      Robust | Mus musculus | GSE99895
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | bone marrow-derived macrophages | lipid A 60 min | Permissive
      
      Robust | Mus musculus | GSE99895
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | bone marrow-derived macrophages | lipid A 120 min | Permissive
      
      Robust | Mus musculus | GSE99895
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | MDA-MB-134 (invasive lobular breast carcinoma) | Treatment: DMSO Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line | Permissive | Homo sapiens | GSE109103
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | MDA-MB-134 (invasive lobular breast carcinoma) | Treatment:100 nM estradiol (E2) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line | Permissive
      
      Robust | Homo sapiens | GSE109103
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | MDA-MB-134 (invasive lobular breast carcinoma) | Treatment:a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr Passage: between 10 and12 CellType: Epithelial ERalpha positive breast cancer cell line | Permissive
      
      Robust | Homo sapiens | GSE109103
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: vehicle treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | mpkCCD (clone 11) | Treatment: 0.1 nM dDAVP treatment Cell type: cultured mouse cortical collecting duct cells (mpkCCD) Passage: 6 to 12 | Permissive
      
      Robust | Mus musculus | GSE98076
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | MC3T3-E1 (preosteoblasts) | Treatment: DMSO vehicle for 1 hour; | Permissive | Mus musculus | GSE62978
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | MC3T3-E1 (preosteoblasts) | Treatment: 100nM fsk for 1 hour; | Permissive | Mus musculus | GSE62978
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | WA01 (H1, human embryonic stem cells) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BSN | MA0018.4 | 
  
    
    | CREB1 | K562 (myelogenous leukemia) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BSO | MA0018.4 | 
  
    
    | CREB1 | GM12878 (female B-cells lymphoblastoid cell line) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BUF | MA0018.4 | 
  
    
    | CREB1 | Ishikawa (endometrial adenocarcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BUR | MA0018.4 | 
  
    
    | CREB1 | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR000BVL | MA0018.4 | 
  
    
    | CREB1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR620DUQ | MA0018.4 | 
  
    
    | CREB1 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR897JAS | MA0018.4 | 
  
    
    | CREB1 | HepG2 (hepatoblastoma) |  | Permissive
      
      Robust | Homo sapiens | ENCSR112ALD | MA0018.4 | 
  
    
    | CREB1 | BMDM (bone marrow-derived macrophages) |  | Permissive
      
      Robust | Mus musculus | GSE64844
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | hepatocytes |  | Permissive
      
      Robust | Mus musculus | GSE72084
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | brown preadipocytes |  | Permissive
      
      Robust | Mus musculus | GSE76619
              
            
          
            
            ... | MA0018.4 | 
  
    
    | CREB1 | LNCaP (prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE63034 | MA0018.4 | 
  
    
    | CREB1 | HepG2 (hepatoblastoma) |  | Permissive | Homo sapiens | GSE72082 | MA0018.4 | 
  
    
    | CREB1 | LNCaP-abl (Prostate carcinoma) | SHCTR | Permissive | Homo sapiens | GSE63034 | MA0018.4 | 
  
    
    | CREB1 | LNCaP-abl (Prostate carcinoma) | SHFOXA1 | Permissive | Homo sapiens | GSE63034 | MA0018.4 | 
  
    
    | CREB1 | KG1 (acute myeloid leukemia) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE74928 | MA0018.4 | 
  
    
    | CREB1 | KG1 (acute myeloid leukemia) | XX65023 | Permissive
      
      Robust | Homo sapiens | GSE74928 | MA0018.4 | 
  
    
    | CREB1 | LNCaP-abl (Prostate carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE63034 | MA0018.4 |